1. Academic Validation
  2. Filicinic acid based meroterpenoids from Hypericum elodeoides and their anti-Alzheimer's disease effects

Filicinic acid based meroterpenoids from Hypericum elodeoides and their anti-Alzheimer's disease effects

  • Bioorg Chem. 2024 Sep 2:153:107787. doi: 10.1016/j.bioorg.2024.107787.
Jing-Dian Li 1 Shou-Lun He 1 Guang-Hui Wang 1 Jun-Jie Chen 1 Xiang-Zhong Liu 1 Tian-Qi Wang 1 Mi Zhou 1 Chun-Chun Du 1 Hai-Feng Chen 2 Wen-Jing Tian 3
Affiliations

Affiliations

  • 1 Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, PR China.
  • 2 Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, PR China. Electronic address: haifeng@xmu.edu.cn.
  • 3 Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, PR China. Electronic address: tianwj@xmu.edu.cn.
Abstract

(±)-Elodeoidileons A-L (1-12), 12 pairs of previously undescribed filicinic acid based meroterpenoids were isolated from Hypericum elodeoides with unique linear or angular 6/6/6 ring core. Modern spectroscopic techniques, modified Mosher's method and quantum chemical calculations were used to identify the planner structures and configurations of 1-12. Additionally, the potential biosynthetic pathways for 1-12 were anticipated. Moreover, biological activity assessments suggested that 1a, 5a, and 11b could activate Retinoid X receptor-α (RXRα) transcription and enhance the ATP-binding cassette transporter A1 (ABCA1) protein's expression. Fluorescence titration assay suggested that 1a might have a direct interaction with the RXRα-LBD protein, with an estimated Kd value of 5.85 μM. Moreover, molecular docking study confirmed the binding of 1a to RXRα and further validated by cellular thermal shift assay (CETSA). Thus, compound 1a may promote β-amyloid (Aβ) clearance by targeting RXRα and upregulating the expression of the ABCA1 protein, showing promise as anti-Alzheimer's agent.

Keywords

Alzheimer’s disease; Meroterpenoids; Retinoid X receptor-α (RXRα).

Figures
Products